Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Among patients with double-seronegative myasthenia gravis (dSN-MG) who do not have detectable antibodies against acetylcholine receptor or musclespecific tyrosine kinase, autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4-Ab) have been detected recently. The purpose of this study was to develop an in-house cell-based assay (CBA) to detect LRP4-Ab and to apply it to samples from patients with MG. Methods The complementary DNA of LRP4 fused into a vector plasmid containing GFP was transfected into human embryonic kidney 293 (HEK293) cells. LRP4 expression in the transfected HEK293 cells was assessed using the reverse-transcription polymerase chain reaction (RT-PCR), Western blotting, and immunocytochemistry. The CBA included 252 sera collected from 202 patients with MG and 38 with other neuromuscular diseases, and 12 healthy controls. The transfected HEK293 cells were incubated using sera and antihuman immunoglobulin G antibodies conjugated with Alexa Fluor 594. The presence of LRP4-Ab was determined based on the fluorescence intensity and the localization in fluorescence microscopy. Results The expressions of the mRNA and protein of LRP4 in the transfected HEK293 cells were confirmed using RT-PCR and Western blotting, respectively. Immunocytochemistry indicated LPR4 expression on the cell membrane. Among 202 patients with MG including 53 with dSN-MG, LRP4-Ab were positive in 3 patients who were all double seronegative. LRP4-Ab were not detected in the patients with other neuromuscular diseases or the healthy controls. Conclusions A CBA for detecting LRP4-Ab associated with MG has been developed, and was used to find LRP4-Ab in the sera of patients with MG.
Abstract
Background and Purpose Among patients with double-seronegative myasthenia gravis (dSN-MG) who do not have detectable antibodies against acetylcholine receptor or musclespecific tyrosine kinase, autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4-Ab) have been detected recently. The purpose of this study was to develop an in-house cell-based assay (CBA) to detect LRP4-Ab and to apply it to samples from patients with MG. Methods The complementary DNA of LRP4 fused into a vector plasmid containing GFP was transfected into human embryonic kidney 293 (HEK293) cells. LRP4 expression in the transfected HEK293 cells was assessed using the reverse-transcription polymerase chain reaction (RT-PCR), Western blotting, and immunocytochemistry. The CBA included 252 sera collected from 202 patients with MG and 38 with other neuromuscular diseases, and 12 healthy controls. The transfected HEK293 cells were incubated using sera and antihuman immunoglobulin G antibodies conjugated with Alexa Fluor 594. The presence of LRP4-Ab was determined based on the fluorescence intensity and the localization in fluorescence microscopy. Results The expressions of the mRNA and protein of LRP4 in the transfected HEK293 cells were confirmed using RT-PCR and Western blotting, respectively. Immunocytochemistry indicated LPR4 expression on the cell membrane. Among 202 patients with MG including 53 with dSN-MG, LRP4-Ab were positive in 3 patients who were all double seronegative. LRP4-Ab were not detected in the patients with other neuromuscular diseases or the healthy controls. Conclusions A CBA for detecting LRP4-Ab associated with MG has been developed, and was used to find LRP4-Ab in the sera of patients with MG.
참고문헌 (22)
- Gilhus NE, "Myasthenia gravis", Nat Rev Dis Primers, 5, pp.30~ (2019)
- Gilhus NE, "Myasthenia gravis : subgroup classification and therapeutic strategies", Lancet Neurol, 14, pp.1023~1036 (2015)
- Poulas K, "Anti-MuSKand anti-AChR-positive myasthenia gravis induced by d-penicillamine", J Neuroimmunol, 250, pp.94~98 (2012)
- Pevzner A, "Anti-LRP4 autoantibodies in AChR-and MuSK-antibody-negative myasthenia gravis", J Neurol, 259, pp.427~435 (2012)
- Hong Y, "Multiple antibody detection in ‘seronegative’ myasthenia gravis patients", Eur J Neurol, 24, pp.844~850 (2017)
- Li Y, "Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis", Muscle Nerve, 56, pp.938~942 (2017)
- Yan M, "Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis", Ann N Y Acad Sci, 1413, pp.126~135 (2018)
- Zisimopoulou P, "A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis", J Autoimmun, 52, pp.139~145 (2014)
- Zong Y, "Structural basis of agrin-LRP4-MuSK signaling", Genes Dev, 26, pp.247~258 (2012)
- Tüzün E, "Complement associated pathogenic mechanisms in myasthenia gravis", Autoimmun Rev, 12, pp.904~911 (2013)
- Ulusoy C, "Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL", 6 mice, 2017, pp.46, 490~499
- Rodriguez Cruz PM, "Use of cellbased assays in myasthenia gravis and other antibody-mediated diseases", Exp Neurol, 270, pp.66~71 (2015)
- 강은숙, "Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder", Annals of Laboratory Medicine, 32(5), pp.331~338 (2012), 대한진단검사의학회
- 김민주, "Evaluating an In-House Cell-Based Assay for Detecting Antibodies Against Muscle-Specific Tyrosine Kinase in Myasthenia Gravis", Journal of Clinical Neurology, 17(3), pp.400~408 (2021), 대한신경과학회[DOI]
- Higuchi O, "Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis", Ann Neurol, 69, pp.418~422 (2011)
- Marino M, "Flow cytofluorimetric analysis of anti-LRP4(LDL receptor-related protein 4)autoantibodies in Italian patients with myasthenia gravis", PLoS One, 10, pp.e0135378~ (2015)
- Cossins J, "The search for new antigenic targets in myasthenia gravis", Ann N Y Acad Sci, 1275, pp.123~128 (2012)
- Gallardo E, "Cortactin autoantibodies in myasthenia gravis", Autoimmun Rev, 13, pp.1003~1007 (2014)
- Rodríguez Cruz PM, "Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis", JAMA Neurol, 72, pp.642~649 (2015)
- Rivner MH, "Clinical features of LRP4", agrin-antibody-positive myasthenia gravis : a multicenter study, 2020, pp.62, 333~343
- Zhang B, "Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis", Arch Neurol, 69, pp.445~451 (2012)
- Bacchi S, "Autoantibodies to low-density lipoprotein receptor-related protein 4 in double seronegative myasthenia gravis : a systematic review", Can J Neurol Sci, 45, pp.62~67 (2018)